Saturday, October 3, 2026

USD/CNH Went Down By Over 1% In The Last 10 Sessions

ViaNews Editorial Team

January 16, 2024

USD/CNH Went Down By Over 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.3% for the last 10 sessions. At 06:09 EST on Tuesday, 16 January, USD/CNH (USDCNH) is $7.22.

USD/CNH's yearly highs and lows, it's 0.497% up from its 52-week low and 0.024% down from its 52-week high.

News about

  • Usd/jpy forecast: usd/jpy continues to see volatility on Friday - 15 January 2024. According to DailyForex on Monday, 15 January, "At the end of the day, the USD/JPY currency pair experienced a downturn in response to the weaker PPI data. ", "Despite this setback, there are several crucial factors to consider in the USD/JPY currency pair."
  • Usd/jpy will struggle to hold above 146/147 levels – ING. According to FXStreet on Monday, 15 January, "We think 152 probably was the top for USD/JPY and it will struggle to hold above 146/147 levels now. "
  • Usd/jpy climbs in light trading and faces resistance at around 146.00. According to FXStreet on Monday, 15 January, "Despite that, the Greenback (USD) remains strong across the board, as the USD/JPY exchanges hands at 145.79, up by 0.63%.", "The daily chart portrays the pair at the brisk of shifting bullish, as the USD/JPY spot price is near the bottom of the Ichimoku Cloud (Kumo). "
  • Usd/jpy holds above 145.00 despite weaker US dollar. According to FXStreet on Monday, 15 January, "This, in turn, might cap the upside of the Greenback and act as a headwind for the USD/JPY pair. ", "The USD/JPY pair gained traction above the 145.00 mark during the early Asian session on Monday. "
  • Usd/jpy gathers strength under the 146.00 barrier on the renewed US dollar demand. According to FXStreet on Tuesday, 16 January, "The USD/JPY pair holds positive ground below the 146.00 barrier during the early Asian session on Tuesday. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com